These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience. Price MJ; Reddy VY; Valderrábano M; Halperin JL; Gibson DN; Gordon N; Huber KC; Holmes DR JACC Cardiovasc Interv; 2015 Dec; 8(15):1925-1932. PubMed ID: 26627989 [TBL] [Abstract][Full Text] [Related]
8. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. Bajwa RJ; Kovell L; Resar JR; Arbab-Zadeh A; Mandal K; Calkins H; Berger RD Clin Cardiol; 2017 Oct; 40(10):825-831. PubMed ID: 28750152 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk. Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322 [TBL] [Abstract][Full Text] [Related]
10. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation. Black-Maier E; Piccini JP; Granger CB J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437 [TBL] [Abstract][Full Text] [Related]
11. Approaches to Left Atrial Appendage Closure: Device Design, Performance, and Limitations. Dave AS; Valderrábano M Methodist Debakey Cardiovasc J; 2017; 13(3):106-113. PubMed ID: 29743994 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillation. Ussia GP; Mulè M; Cammalleri V; Scarabelli M; Barbanti M; Immè S; Mangiafico S; Marchese A; Galassi AR; Tamburino C Catheter Cardiovasc Interv; 2009 Aug; 74(2):217-22. PubMed ID: 19472361 [TBL] [Abstract][Full Text] [Related]
13. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428 [TBL] [Abstract][Full Text] [Related]
14. Left atrial appendage occlusion for the reduction of stroke and embolism in patients with atrial fibrillation. Gibson DN; Price MJ; Ahern TS; Teirstein PS J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):131-7. PubMed ID: 22193834 [No Abstract] [Full Text] [Related]
15. Percutaneous Left Atrial Appendage Closure: Current Devices and Clinical Outcomes. Asmarats L; Rodés-Cabau J Circ Cardiovasc Interv; 2017 Nov; 10(11):. PubMed ID: 29146668 [TBL] [Abstract][Full Text] [Related]
16. The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation. Amorosi SL; Armstrong S; Da Deppo L; Garfield S; Stein K Europace; 2014 Aug; 16(8):1131-6. PubMed ID: 24687964 [TBL] [Abstract][Full Text] [Related]
17. Percutaneous left atrial appendage occlusion: New perspectives for the method. Gorczyca-Michta I; Wożakowska-Kapłon B Cardiol J; 2017; 24(5):554-562. PubMed ID: 28281734 [TBL] [Abstract][Full Text] [Related]
18. Is the left atrial appendage more than a simple appendage? Hara H; Virmani R; Holmes DR; Buchbinder M; Lesser JR; Van Tassel RA; Mooney MR; Schwartz RS Catheter Cardiovasc Interv; 2009 Aug; 74(2):234-42. PubMed ID: 19360867 [TBL] [Abstract][Full Text] [Related]
20. Mechanical closure of the left atrial appendage: is it time to be more aggressive? Cox JL J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1018-1027.e2. PubMed ID: 23993272 [No Abstract] [Full Text] [Related] [Next] [New Search]